Extended Lymphadenectomy Fails to Improve Survival in Bladder Cancer
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 3, 2024 -- For patients with muscle-invasive bladder cancer, extended lymphadenectomy does not improve disease-free or overall survival compared with standard lymphadenectomy, according to a study published in the Oct. 3 issue of the New England Journal of Medicine.
Seth P. Lerner, M.D., from the Baylor College of Medicine in Houston, and colleagues randomly assigned 592 eligible patients with localized muscle-invasive bladder cancer of clinical stage T2 to T4a with two or fewer positive nodes to undergo extended lymphadenectomy, including removal of common iliac, presciatic, and presacral nodes, or bilateral standard lymphadenectomy (292 and 300 patients, respectively).
Overall, 57 percent of the patients had received neoadjuvant chemotherapy. The researchers found that at a median follow-up of 6.1 years, recurrence or death had occurred in 45 and 42 percent of patients in the extended- and standard-lymphadenectomy groups, respectively, and the estimated five-year disease-free survival rates were 56 and 60 percent, respectively (hazard ratio, 1.10; 95 percent confidence interval, 0.86 to 1.40; P = 0.45). At five years, overall survival was 59 and 63 percent in the extended- and standard-lymphadenectomy groups, respectively (hazard ratio, 1.13; 95 percent confidence interval, 0.88 to 1.45). Adverse events of grade 3 to 5 occurred in 54 and 44 percent of patients in the extended- and standard-lymphadenectomy groups, respectively; death within 90 days after surgery occurred in 7 and 2 percent, respectively.
"We found that extended lymphadenectomy did not improve disease-free survival or overall survival as compared with standard lymphadenectomy among patients with localized muscle-invasive bladder cancer undergoing radical cystectomy," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Thresholds for Preop Serum Calcitonin Predict Lymph Node Metastasis in Thyroid Cancer
WEDNESDAY, July 2, 2025 -- Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in patients with medullary thyroid...
No Link Found for Preprocedural Fasting and Witnessed Pulmonary Aspiration
WEDNESDAY, July 2, 2025 -- For patients undergoing surgical procedures, there is no association between liberal preprocedural fasting policies and witnessed aspiration, according...
More Than One in 10 Surgical Patients Face Food Insecurity
FRIDAY, June 20, 2025 -- Food insecurity is a significant burden among U.S. surgical patients, according to a study published online June 18 in JAMA Surgery. Annabelle...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.